SocialPicks Sentiment:
** v.s.
other stocks
|
This Quarter's Sentiment:
|
|
|
NSTK Analysis & Videos »
NSTK: Bull or Bear?
Great price on pills, for once!
NSTK
|
|
|
I've had my eye on this for a long time and I never thought it would get this low. This is a risky play like all pharm stocks but I feel that given the history of the company it's due for a least a little shot in the arm to at least 2.30 or so. Plus some news is suppose to be released soon about one of its cancer research projects. I hope its good news.
A target of around 1.90 would have been more realistic but, what the hell, this is the stock market and we've all been at the 'casino' lately!
|
my continuing evaluation from 12 months ago
NSTK
|
|
|
NSTK: BEING IN BUSINESS FOR 24 YEARS, BECOMING ACQUAINTED WITH BROKERAGE HOUSES, RESEARCH FRMS, STAR MINE ANALYSTS, AND THE REST OF THE CIRCLE OF EVERYDAY BUSINESS ASSOCIATES OF WALL STREET, IT CAN BE UNDERSTOOD HOW FUNDS, RESEARCH FIRMS, AND ANALYSTS, COULD FIND IT QUITE EASY TO PLAY FAVORITISM OR SORT OF GO WITH THE FLOW IN PARTICIPATING IN <> <> RECOMMENDING A SPECIFIC STOCK. STILL AT THIS POINT IN TIME, 5/15/08 RESEARCH FIRMS, THEIR TARGET PRICES AND STAR MINE ANALYST ARE STILL PLUGGING NSTK AND MANY HAVEN'T ADJUSTED THEIR TARGET PRICES AS OF YET. SINCE THE ...
|
Bearish on NSTK ...
NSTK
|
|
|
5/11/08 WHAT DOES RESEARCH FIRMS, THEIR TARGET PRICES, JIM CRAMER, AND STAR MINE ANALYST,TAUNYA SELL, OF RAGEN MACKENZIE ALL HAVE IN COMMON WITH NSTK? ANSWER:TOUTING& PUMPING. FROM $18 TO $1.18-CHRONIC MISINFORMATION ABOUT THIS STOCK! There is no excuses for the above, with all the latest technology in todays world, their staffs, and actual statistics and companies past history to date, to be so wrong as they have been. The events in 2007 were all too evident and mislead shareholders which caused financial ruins to many.
|
Bearish on NSTK ...
NSTK
|
|
|
There is no doubt that all are witnessing the Funeral of NSTK as of Feb.17th. The Book Value of $1.93 will have to be adjusted before the Year end earnings report comes out on March 5th.*New Lows are still being made showing no further support or bottoming, therefore it looks like no end in sight for stock price as it continues to deteriorate What a disaster after 24 years, not for management but for investors financially.
|
Touting stars getting picked off one by one!
NSTK
|
|
|
Biggest Cheerleader of all-JIM CRAMER-GONE Next Biggest Cheerleader-Robert Uhl, whose chronic upgrades and high target prices were never met-GONE Robert Uhl's former employer-Friedman,billings,Ramsey group-Dropped all coverage on NSTK-GONE Whose left, The Institutions? With hardly any Revenue, higher expenses, and no major drug approvals/ or close to getting approved, management continues to get paid and still have their options and raises. Funny but it's the Chinese New Year right now, "YEAR OF THE RAT", and life goes on for management and investors are left financially ruined. I wo...
|
BURN RATE JUST DOUBLED FOR NSTK
NSTK
|
|
|
02/08/08 NSTK:WITH NEW SUBSIDIARY AND NEWLY APPOINTED DIRECTORS, I BELIEVE NSTK JUST DOUBLED THEIR 'BURN RATE'. PRIOR TO THIS FORMATION, THEY ANNOUNCED THAT THEY HAD 1 YEAR LEFT OF OPERATING EXPENSES. WITH 26 DAYS LEFT BEFORE 'YEAR END EARNINGS REPORT', I ALSO BELIEVE BY THEN THE STOCK PRICE SHOULD JUST BE UNDER $2.00 DOLLARS($1.96) LOGICALLY, NSTK IS STILL IN BEARISH TREND WITH NO END IN SIGHT. JUST BECAUSE THE STOCK IS AT NEW LOWS DOESN'T MEAN INVESTORS SHOULD BUY. 'NSTK' IS INCREASING THEIR DEBT, WHILE REVENUES DECLINE. JUST TOO MANY NEGATIVES FOR ANY INVESTOR. AND DON'T LISTEN TO R...
|
$3.42 TODAY -JAN.14TH BUT $2.75 BEFORE LONG
NSTK
|
|
|
IN SEPTEMBER I POSTED ON ANOTHER SITE, THAT 'NSTK' HAS THE INGREDIENTS FOR FAILURE WHICH HAS COME TO FRUITION. AT TODAY'S PRICE $3.42 I ONLY SEE FURTHER DETERIORATION DUE TO COMPANY LOSING THEIR CREDITABILITY AND THEIR YEAR END EARNINGS REPORT DUE OUT IN MARCH 2008 FOR THE DECEMBER CLOSE OF 2007. EVEN THE RESEARCH FIRMS THAT HAVE COVERED THIS STOCK FOR YEARS HAVE BEEN SO 'WRONG' ON THEIR UPGRADES AND TARGET PRICES THAT THEY HAVE BECOME THE ICING ON THE CAKE! CHANGE IS IN ORDER FOR A COMEBACK, IF ANY! FIRST MANAGEMENT MUST SET THE EXAMPLE TO ALL INVESTORS & SECONDLY THEY SHOULD CHANGE TH...
|
Technicals Look Great
NSTK
|
|
|
This stock looks as though it has reached, or is very near, the low. This stock is a good buy over the coming weeks and months depending on how quick it rises. Nastech has also been publicized by Jim Cramer--on March 16--which means there will be increased volume in the near term. Overall, this is a good company with tons of cash and looks cheap. Very risky, but rewards look more likely.
|
People Bullish on NSTK
People Bearish on NSTK
|
ROCK-STAR INVESTORS
|
|
POPULAR STOCKS
|
|
TODAY'S HEADLINES
|
|
TODAY'S TOP PICKS
|
|
|
| StreetInsider.com on NSTK |
More Resources
|
About Nastech Pharmaceutical Company Inc.
- Answers.com
